Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Guanxinjing capsule for chronic stable angina
ChiCTR1800014258Phase 4Not yet recruiting
- Sponsor
- Tianjin University of Traditional Chinese Medicine
- Start
- Apr 2018
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of Guanxinjing in angina pectoris and coronary arteriosclerosis (2 arms), sponsored by Tianjin University of Traditional Chinese Medicine. Primary endpoints: Total exercise time during exercise tolerance testing at week 8 and Angina symptom score at week 8. Planned start Apr 2018; status: not yet recruiting.
02
Drugs
Guanxinjing
03
Conditions
angina pectoriscoronary arteriosclerosis
Beyond the preview
Go deeper on ChiCTR1800014258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014258.